Stilla is exhibiting at the
11th Annual NGS & Clinical Diagnostics Congress
07-08th of November 2019, London (UK)
Come visit us at booth #23 and attend our talk on
“Detection of PIK3CA mutations in plasma ctDNA by digital PCR for the selection of alpelisib treatment in routine clinical practice in advanced breast cancer patients.”
By Véronique Quillien (Centre Eugène Marquis, Rennes) on Friday 08th of November at 10.00 am.
